List of Oculeve patents | 5 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10426958 Intranasal stimulation for enhanced release of ocular mucins and other tear proteins	Patent 10426958 was granted and assigned to Oculeve on October, 2019 by the United States Patent and Trademark Office.	Oculeve	United States Patent and Trademark Office	10426958	October 1, 2019
‌ US Patent 10799695 Nasal stimulation devices and methods	Patent 10799695 was granted and assigned to Oculeve on October, 2020 by the United States Patent and Trademark Office.	Oculeve	United States Patent and Trademark Office	10799695	October 13, 2020
‌ US Patent 10940310 Nasal stimulation for rhinitis, nasal congestion, and ocular allergies	Patent 10940310 was granted and assigned to Oculeve on March, 2021 by the United States Patent and Trademark Office.	Oculeve	United States Patent and Trademark Office	10940310	March 9, 2021
‌ US Patent 10835738 Nasal stimulation devices and methods	Patent 10835738 was granted and assigned to Oculeve on November, 2020 by the United States Patent and Trademark Office.	Oculeve	United States Patent and Trademark Office	10835738	November 17, 2020
‌ US Patent 10799696 Polymer formulations for nasolacrimal stimulation	Patent 10799696 was granted and assigned to Oculeve on October, 2020 by the United States Patent and Trademark Office.	Oculeve	United States Patent and Trademark Office	10799696	October 13, 2020